Literature DB >> 14960598

Ectopic expression of the catalytic subunit of telomerase protects against brain injury resulting from ischemia and NMDA-induced neurotoxicity.

Hyo Jung Kang1, Yoon Sik Choi, Seung-Beom Hong, Kee-Won Kim, Ran-Sook Woo, Seok Joon Won, Eun Ju Kim, Hee Kyung Jeon, So-Young Jo, Tae Kook Kim, Robert Bachoo, Ian J Reynolds, Byoung Joo Gwag, Han-Woong Lee.   

Abstract

The catalytic subunit of telomerase reverse transcriptase (TERT) protects dividing cells from replicative senescence in vitro. Here, we show that expression of TERT mRNA is induced in the ipsilateral cortical neurons after occlusion of the middle cerebral artery in adult mice. Transgenic mice that overexpress TERT showed significant resistance to ischemic brain injury. Among excitotoxicity, oxidative stress, and apoptosis comprising of routes of ischemic neuronal death, NMDA receptor-mediated excitotoxicity was reduced in forebrain cell cultures overexpressing TERT. NMDA-induced accumulation of cytosolic free Ca2+ ([Ca2+]c) was reduced in forebrain neurons from TERT transgenic mice, which was attributable to the rapid flow of [Ca2+]c into the mitochondria from the cytosol without change in Ca2+ influx and efflux through the plasma membrane. The present study provides evidence that TERT is inducible in postmitotic neurons after ischemic brain injury and prevents NMDA neurotoxicity through shift of the cytosolic free Ca2+ into the mitochondria, and thus plays a protective role in ameliorating ischemic neuronal cell death.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 14960598      PMCID: PMC6730349          DOI: 10.1523/JNEUROSCI.4082-03.2004

Source DB:  PubMed          Journal:  J Neurosci        ISSN: 0270-6474            Impact factor:   6.167


  42 in total

1.  Excitotoxic and Radiation Stress Increase TERT Levels in the Mitochondria and Cytosol of Cerebellar Purkinje Neurons.

Authors:  Erez Eitan; Carmel Braverman; Ailone Tichon; Daniel Gitler; Emmette R Hutchison; Mark P Mattson; Esther Priel
Journal:  Cerebellum       Date:  2016-08       Impact factor: 3.847

Review 2.  DNA damage responses in neural cells: Focus on the telomere.

Authors:  P Zhang; C Dilley; M P Mattson
Journal:  Neuroscience       Date:  2007-01-04       Impact factor: 3.590

3.  Telomerase expression in amyotrophic lateral sclerosis (ALS) patients.

Authors:  Bruna De Felice; Anna Annunziata; Giuseppe Fiorentino; Francesco Manfellotto; Raffaella D'Alessandro; Rita Marino; Marco Borra; Elio Biffali
Journal:  J Hum Genet       Date:  2014-08-21       Impact factor: 3.172

4.  Efficient Transformation of Primary Human Mesenchymal Stromal Cells by Adenovirus Early Region 1 Oncogenes.

Authors:  Thomas Speiseder; Helga Hofmann-Sieber; Estefanía Rodríguez; Anna Schellenberg; Nuray Akyüz; Judith Dierlamm; Thilo Spruss; Claudia Lange; Thomas Dobner
Journal:  J Virol       Date:  2016-12-16       Impact factor: 5.103

5.  Telomerase regulates MYC-driven oncogenesis independent of its reverse transcriptase activity.

Authors:  Cheryl M Koh; Ekta Khattar; Shi Chi Leow; Chia Yi Liu; Julius Muller; Wei Xia Ang; Yinghui Li; Guido Franzoso; Shang Li; Ernesto Guccione; Vinay Tergaonkar
Journal:  J Clin Invest       Date:  2015-04-20       Impact factor: 14.808

Review 6.  Making the most of a little: dosage effects in eukaryotic telomere length maintenance.

Authors:  Lea Harrington
Journal:  Chromosome Res       Date:  2005       Impact factor: 5.239

7.  The telomerase reverse transcriptase regulates chromatin state and DNA damage responses.

Authors:  Kenkichi Masutomi; Richard Possemato; Judy M Y Wong; Jennifer L Currier; Zuzana Tothova; Judith B Manola; Shridar Ganesan; Peter M Lansdorp; Kathleen Collins; William C Hahn
Journal:  Proc Natl Acad Sci U S A       Date:  2005-05-31       Impact factor: 11.205

8.  No attenuation of the ATM-dependent DNA damage response in murine telomerase-deficient cells.

Authors:  Natalie Erdmann; Lea A Harrington
Journal:  DNA Repair (Amst)       Date:  2008-12-25

9.  [Enhanced control of proliferation in telomerized cells].

Authors:  E E Egorov; M V Moldaver; Kh S Vishniakova; S M Terekhov; E B Dashinimaev; I B Cheglakov; I Iu Toropygin; K N Iarygin; P M Chumakov; L I Korochkin; G A Antonova; E Iu Rybalkina; I N Saburina; N S Burnaevskiĭ; A V Zelenin
Journal:  Ontogenez       Date:  2007 Mar-Apr

Review 10.  Oxidative stress, DNA damage, and the telomeric complex as therapeutic targets in acute neurodegeneration.

Authors:  Joshua A Smith; Sookyoung Park; James S Krause; Naren L Banik
Journal:  Neurochem Int       Date:  2013-02-17       Impact factor: 3.921

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.